Risk Management Plan for Pharmacovigilance
A comprehensive pharmacovigilance risk management plan
identifies safety concerns while maintaining regulatory
compliance throughout the entire product lifecycle.
identifies safety concerns while maintaining regulatory
compliance throughout the entire product lifecycle.
Our Approach to Developing a Comprehensive Risk Management Plan
Based on the medicinal product data and risks provided by the client, we support the systematic process of preparing a risk management plan for pharmacovigilance. This document ensures that clinical trials and post-marketing surveillance data comply with all regulatory requirements.
Risk Identification and Assessment
Using the provided data, PV experts identify important risks, missing information, and new risks and all the information that can be relevant for creating the RMP. This assessment of the product's safety profile ensures medicines meet safety standards without conducting new studies.
Risk Minimisation
Strategies
We assist you in developing ways to effectively manage your medicinal products’ safety profile by creating management plans that ensure the benefits of using a particular medication significantly outweigh its potential risks in a clinical environment on a daily basis.
Monitoring and Evaluation Techniques
Continuous evaluation of existing and new data allows the marketing authorisation holder to measure the effectiveness of risk minimisation. We assist in preparing an updated RMP that incorporates safety information from various sources.
Risk Communication and Reporting
Clear risk communication is critical for healthcare professionals. While the marketing authorisation holder is responsible for reporting, our services facilitate the development of periodic documentation and ensure compliance with regulatory authorities’ requirements.
Key Benefits of Implementing a Risk Management Plan in Pharmacovigilance
Our risk management plan services help companies summarise the safety profile of their pharmaceutical products. We ensure the management plan reflects that the benefits of the medicinal product outweigh its risks on a continuous basis.
Enhanced Patient Safety
We ensure patient safety by organising risk minimisation and mitigation strategies into a coherent document. This process protects patients by clearly outlining the safety information gathered over the covered period.
Compliance with Regulatory Requirements
We support the marketing authorisation holder in maintaining regulatory compliance with local requirements and health authorities. We prepare the safety documentation required for submission.
Early Detection of Potential Drug Safety Issues
Advanced evaluation of reported adverse events and signal detection results helps identify emerging risks or areas of interest in post-marketing surveillance.
DrugCard Platform in Numbers
121+
Countries
Medical journals coverage
Medical journals coverage
2200+
Local journals
Continuously monitored
Continuously monitored
~2
Weeks
New country Easily Added
New country Easily Added
Risk Management Plan Lifecycle
The management plan summarises the safety data of a medicinal product over a specific period. This systematic process ensures that mitigating risks remains the marketing authorisation holder's priority.
Initial Development and Risk Profiling
Our PV team structures the initial safety specifications using existing data. We assist in identifying the safety profile to protect patients, using the results of previously conducted clinical trials.
Continuous Monitoring and Updates
The updated RMP is created using new data and client-reported adverse events. This ongoing assessment allows the marketing authorisation holder to refine mitigation strategies and identify new risks.
Integration with Other Pharmacovigilance Systems
Our services align risk communication with the client’s reporting and signal detection tools. This strengthens the overall risk management system and all related pharmacovigilance activities.
How We Support You Here
Our pharmacovigilance risk management support helps companies consolidate their safety data and mitigate risks through documentation.
Tailored Solutions for Your Specific Needs
We structure your management plan around specific pharmacovigilance risks. Our mitigation strategies are designed for healthcare professionals and patients based on existing clinical practice data.
Expert Pharmacovigilance Consultation and Support
Our PV experts conduct evaluations of adverse events to enhance drug safety. We offer pharmacovigilance risk management expertise to help the marketing authorisation holder address new safety concerns.
Training and Knowledge Transfer for Your Team
Our team helps your PV team master risk minimisation and reporting standards. We ensure your specialists understand the pharmacovigilance plan and the systematic process of identifying new risks.
Why Choose DrugCard for Your Pharmacovigilance Risk Management Needs
- Regulatory Expertise: Our services ensure your medicinal product documentation meets regulatory and competent authorities’ requirements.
- Benefit-Risk Balance: We focus on pharmacovigilance risk management to demonstrate that the benefits of your medicinal products outweigh risks for your patients.
- Expert Support: Our team of PV experts provides the safety information and reporting structures you need for regulatory compliance.
- Lifecycle Summary: We provide the support needed to summarise the safety profile from clinical trials through post-marketing surveillance periods.
Ready to Ensure Comprehensive Risk Management for Your Products?
- Book a meeting for the demonstraion
- Anwers your additional questions
- Implenetation DrugCard to your pharmacovigilance system
- Tariff plans, pricing, addional features
